Qube Research & Technologies LTD Galapagos Nv Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$122.47 - $213.56 $1.07 Million - $1.86 Million	-8,697 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $1.61 Million - $2.01 Million	8,697 New	8,697 $1.72 Million
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $591,734 - $1.13 Million	-4,138 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $311,527 - $460,128	2,132 Added 106.28%	4,138 $856,000
Q3 2019 Nov 13, 2019	BUY	$130.44 - $187.64 $261,662 - $376,405	2,006 New	2,006 $306,000
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $161,772 - $192,772	-1,830 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$94.51 - $120.23 $172,953 - $220,020	1,830 New	1,830 $182,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.